\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ is\\ a\\ healthy\\ appearing\\ white\\ male\\.\\ \\ laboratory\\ values\\ are\\ unremarkable\\.\ \(0\)\
\-\ patient\\ is\\ treated\\ with\\ bronchial\\ lavage\\ when\\ symptomatic\\ and\\ followed\\ with\\ chest\\ radiographs\\ to\\ assess\\ for\\ evolution\\.\ \(0\)\
\-\ frontal\\ and\\ lateral\\ chest\\ radiographs\\ demonstrate\\ alveolar\\ consolidation\\ and\\ ground\\ glass\\ opacities\\ in\\ a\\ bilaterally\\ symmetric\\ pattern\\ with\\ a\\ predominantly\\ perihilar\\ distribution\\.\\ \\ no\\ pleural\\ effusions\\ are\\ present\\ and\\ the\\ lung\\ volumes\\ are\\ normal\\.\\ \\ the\\ chest\\ ct\\ demonstrates\\ patchy\\ areas\\ of\\ alveolar\\ consolidation\\.\ \(0\)\
\-\ alveolar\\ proteinosis\ \(5\)\
\-\ pulmonary\\ alveolar\\ proteinosis\ \(1\)\
\-\ pulmonary\\ edema\ \(53\)\
\-\ diffuse\\ bronchioalveolar\\ carcinoma\ \(0\)\
\-\ diffuse\\ infection\\ \ \(0\)\
\-\ pulmonary\\ hemorrhage\ \(11\)\
\-\ hypersensitivity\\ pneumonitis\ \(9\)\
\-\ 43\\-year\\-old\\ male\\ with\\ dyspnea\\ and\\ nonproductive\\ cough\\.\ \(1\)\
\-\ pulmonary\\ alveolar\\ proteinosis\\ is\\ a\\ disease\\ characterized\\ by\\ the\\ accumulation\\ of\\ proteinaceous\\ material\\ within\\ the\\ alveolar\\ spaces\\.\\ \\ the\\ cause\\ is\\ unknown\\.\\ \\ it\\ typically\\ affects\\ men\\ between\\ the\\ ages\\ of\\ 30\\ and\\ 50\\,\\ such\\ as\\ this\\ patient\\.\\ \\ patients\\ typically\\ present\\ with\\ a\\ nonproductive\\ cough\\ and\\ dyspnea\\.\ \(0\)\
\-\ chest\\ radiographs\\ demonstrate\\ a\\ bilaterally\\ symmetric\\ and\\ predominantly\\ hilar\\ or\\ perihilar\\ distribution\\ of\\ alveolar\\ consolidation\\ and\\ ground\\ glass\\ opacities\\.\\ \\ on\\ high\\ resolution\\ chest\\ ct\\ the\\ finding\\ of\\ patchy\\ ground\\ glass\\ opacities\\ with\\ thickened\\ septal\\ walls\\ is\\ termed\\ the\\ \\‚\\Ä\\úcrazy\\ paving\\‚\\Ä\\ù\\ pattern\\.\ \(0\)\
\-\ treatment\\ for\\ pap\\ is\\ with\\ bronchial\\ lavage\\.\\ \\ one\\-third\\ of\\ patients\\ will\\ typically\\ improve\\,\\ one\\-third\\ will\\ stay\\ the\\ same\\,\\ and\\ one\\-third\\ with\\ get\\ worse\\.\\ \\ pap\\ may\\ be\\ complicated\\ by\\ infection\\ with\\ nocardia\\,\\ aspergillus\\,\\ mycobacterial\\ or\\ mucor\\ species\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ alveolar\\:\\ 0\\.4454197836142625\ \(0\)\
\-\ proteinosis\\:\\ 0\\.24291134253263008\ \(0\)\
\-\ nonproductive\\:\\ 0\\.18529347177254826\ \(0\)\
\-\ glass\\:\\ 0\\.18295823034055916\ \(0\)\
\-\ ground\\:\\ 0\\.17705502919641003\ \(0\)\
\-\ opacities\\:\\ 0\\.17365076997815776\ \(0\)\
\-\ consolidation\\:\\ 0\\.16810772197160934\ \(0\)\
\-\ chest\\:\\ 0\\.16001056691186866\ \(0\)\
\-\ pap\\:\\ 0\\.15582580078327316\ \(0\)\
\-\ lavage\\:\\ 0\\.1510825651921007\ \(0\)\
\-\ pulmonary\\:\\ 0\\.1478203166375538\ \(0\)\
\-\ perihilar\\:\\ 0\\.14294151665475593\ \(0\)\
\-\ typically\\:\\ 0\\.12768289296351562\ \(0\)\
\-\ and\\:\\ 0\\.1252787057946523\ \(0\)\
\-\ bronchial\\:\\ 0\\.12346444556894592\ \(0\)\
\-\ patchy\\:\\ 0\\.11803668613094002\ \(0\)\
\-\ radiographs\\:\\ 0\\.11796601064959164\ \(0\)\
\-\ the\\:\\ 0\\.10887592585400313\ \(0\)\
\-\ with\\:\\ 0\\.10684409008634178\ \(0\)\
\-\ dyspnea\\:\\ 0\\.10670465577544386\ \(0\)\
\-\ predominantly\\:\\ 0\\.10618406408868751\ \(0\)\
\-\ symmetric\\:\\ 0\\.10391021856756584\ \(0\)\
\-\ distribution\\:\\ 0\\.1028584491246103\ \(0\)\
\-\ is\\:\\ 0\\.09961903927990928\ \(0\)\
\-\ mucor\\:\\ 0\\.09264673588627413\ \(0\)\
\-\ pattern\\:\\ 0\\.09052771402052251\ \(0\)\
\-\ cough\\:\\ 0\\.09052771402052251\ \(0\)\
\-\ bronchioalveolar\\:\\ 0\\.089589188767034\ \(0\)\
\-\ crazy\\:\\ 0\\.089589188767034\ \(0\)\
\-\ paving\\:\\ 0\\.089589188767034\ \(0\)\
\-\ nocardia\\:\\ 0\\.08527981813895535\ \(0\)\
\-\ bilaterally\\:\\ 0\\.08086796019520932\ \(0\)\
\-\ species\\:\\ 0\\.07985065322412901\ \(0\)\
\-\ will\\:\\ 0\\.07804258807416152\ \(0\)\
\-\ aspergillus\\:\\ 0\\.07706218922921466\ \(0\)\
\-\ diffuse\\:\\ 0\\.07604152907160519\ \(0\)\
\-\ proteinaceous\\:\\ 0\\.07421102171495841\ \(0\)\
\-\ infection\\:\\ 0\\.07324468524822488\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.0730288916735603\ \(0\)\
\-\ of\\:\\ 0\\.0711868592594499\ \(0\)\
\-\ evolution\\:\\ 0\\.07099831540649913\ \(0\)\
\-\ volumes\\:\\ 0\\.07099831540649913\ \(0\)\
\-\ termed\\:\\ 0\\.07099831540649913\ \(0\)\
\-\ hypersensitivity\\:\\ 0\\.07011211768122401\ \(0\)\
\-\ pneumonitis\\:\\ 0\\.07011211768122401\ \(0\)\
\-\ are\\:\\ 0\\.0690158060471216\ \(0\)\
\-\ patients\\:\\ 0\\.06821224204745761\ \(0\)\
\-\ stay\\:\\ 0\\.0678258675389813\ \(0\)\
\-\ get\\:\\ 0\\.06594540980859014\ \(0\)\
\-\ demonstrate\\:\\ 0\\.06303681158182256\ \(0\)\
\-\ present\\:\\ 0\\.06221958058310565\ \(0\)\
\-\ affects\\:\\ 0\\.062125905409719705\ \(0\)\
\-\ ages\\:\\ 0\\.0619272413881605\ \(0\)\
\-\ men\\:\\ 0\\.06173222278447296\ \(0\)\
\-\ patient\\:\\ 0\\.05915696305124667\ \(0\)\
\-\ septal\\:\\ 0\\.05901834306547001\ \(0\)\
\-\ improve\\:\\ 0\\.05886969426892038\ \(0\)\
\-\ accumulation\\:\\ 0\\.05857849206127136\ \(0\)\
\-\ complicated\\:\\ 0\\.05748746156934855\ \(0\)\
\-\ walls\\:\\ 0\\.0568583894771315\ \(0\)\
\-\ effusions\\:\\ 0\\.05673692283274042\ \(0\)\
\-\ assess\\:\\ 0\\.05603590732386979\ \(0\)\
\-\ values\\:\\ 0\\.055923438383336514\ \(0\)\
\-\ characterized\\:\\ 0\\.05570200921380612\ \(0\)\
\-\ hilar\\:\\ 0\\.055593000917695035\ \(0\)\
\-\ spaces\\:\\ 0\\.05516781559224221\ \(0\)\
\-\ male\\:\\ 0\\.05398713175604297\ \(0\)\
\-\ by\\:\\ 0\\.05149165871708664\ \(0\)\
\-\ healthy\\:\\ 0\\.05142922456230515\ \(0\)\
\-\ thickened\\:\\ 0\\.05114000356739385\ \(0\)\
\-\ material\\:\\ 0\\.05106891155850779\ \(0\)\
\-\ worse\\:\\ 0\\.05078920552904909\ \(0\)\
\-\ resolution\\:\\ 0\\.04919036899447926\ \(0\)\
\-\ appearing\\:\\ 0\\.04844522940236148\ \(0\)\
\-\ same\\:\\ 0\\.047958355772272185\ \(0\)\
\-\ symptomatic\\:\\ 0\\.04661876780352532\ \(0\)\
\-\ ct\\:\\ 0\\.04616269571955548\ \(0\)\
\-\ unknown\\:\\ 0\\.04594158238468441\ \(0\)\
\-\ pleural\\:\\ 0\\.04563974664368144\ \(0\)\
\-\ laboratory\\:\\ 0\\.04402572083840869\ \(0\)\
\-\ 50\\:\\ 0\\.04234051935200648\ \(0\)\
\-\ or\\:\\ 0\\.04218225324244883\ \(0\)\
\-\ 30\\:\\ 0\\.04135875578066482\ \(0\)\
\-\ cause\\:\\ 0\\.04130207182923224\ \(0\)\
\-\ areas\\:\\ 0\\.04116167063687731\ \(0\)\
\-\ followed\\:\\ 0\\.04094081664949342\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0406444466919489\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.04059143802495342\ \(0\)\
\-\ white\\:\\ 0\\.04000011513451085\ \(0\)\
\-\ finding\\:\\ 0\\.039851119016325896\ \(0\)\
\-\ between\\:\\ 0\\.03939262318311036\ \(0\)\
\-\ frontal\\:\\ 0\\.03902129403708076\ \(0\)\
\-\ such\\:\\ 0\\.038998511143682\ \(0\)\
\-\ treated\\:\\ 0\\.03775427650749769\ \(0\)\
\-\ lung\\:\\ 0\\.036880232260620316\ \(0\)\
\-\ for\\:\\ 0\\.03675128378803315\ \(0\)\
\-\ when\\:\\ 0\\.03662234262411244\ \(0\)\
\-\ carcinoma\\:\\ 0\\.036264456430623766\ \(0\)\
\-\ edema\\:\\ 0\\.036159399077350884\ \(0\)\
\-\ high\\:\\ 0\\.034456533499841714\ \(0\)\
\-\ it\\:\\ 0\\.031034221146465854\ \(0\)\
\-\ may\\:\\ 0\\.030509523504061244\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03045845076906497\ \(0\)\
\-\ lateral\\:\\ 0\\.030087952603299162\ \(0\)\
\-\ treatment\\:\\ 0\\.028879956850179366\ \(0\)\
\-\ within\\:\\ 0\\.027923023152568154\ \(0\)\
\-\ disease\\:\\ 0\\.025449148734618805\ \(0\)\
\-\ normal\\:\\ 0\\.024753683101935094\ \(0\)\
\-\ be\\:\\ 0\\.02459403513553027\ \(0\)\
\-\ as\\:\\ 0\\.024356101724222274\ \(0\)\
\-\ this\\:\\ 0\\.02083260097834756\ \(0\)\
\-\ no\\:\\ 0\\.01971527865711879\ \(0\)\
\-\ on\\:\\ 0\\.01831045790741305\ \(0\)\
\-\ to\\:\\ 0\\.015156683275853202\ \(0\)\
\-\ in\\:\\ 0\\.015082082112160023\ \(0\)\
